Aakaar Medical

Is Aakaar Medical overvalued or undervalued?

As of November 17, 2025, Aakaar Medical is considered overvalued with a PE ratio of 18.23 and an EV to EBITDA ratio of 12.87, despite being lower than some peers like Sun Pharma and Divi's Lab, while its recent stock performance has underperformed the Sensex with returns of -3.24% over the past week and -11.37% over the past month.

As of 17 November 2025, Aakaar Medical's valuation grade has moved from very expensive to expensive. The company is currently considered overvalued based on its financial metrics. The PE ratio stands at 18.23, while the EV to EBITDA ratio is 12.87, and the ROCE is 15.34%. <BR><BR>In comparison to its peers, Aakaar Medical's PE ratio is significantly lower than that of Sun Pharma, which has a PE of 36.69, and Divi's Lab, which is at 69.78. However, it is higher than some peers like Dr. Reddy's Labs, which has a PE of 17.98. The recent performance shows that Aakaar Medical has underperformed the Sensex over the past week and month, with stock returns of -3.24% and -11.37%, respectively, reinforcing the notion of its overvaluation.

Why is Aakaar Medical Technologies Ltd falling/rising?

As of 18-Apr, Aakaar Medical Technologies Ltd's stock price is at 60.50, down 0.98%. The decline is due to today's underperformance, reduced investor participation, and mixed moving averages, despite positive trends over the past week and month.

As of 18-Apr, Aakaar Medical Technologies Ltd's stock price is currently at 60.50, reflecting a decrease of 0.6, or 0.98%. This decline can be attributed to several factors. Despite a positive performance over the past week and month, where the stock rose by 5.86% and 18.40% respectively, it has underperformed today by 1.15% against its sector. <BR><BR>Additionally, the stock's moving averages indicate mixed performance; it is higher than the 5-day, 20-day, and 50-day moving averages but lower than the 100-day and 200-day moving averages, suggesting a potential loss of momentum. Furthermore, there has been a significant drop in investor participation, with delivery volume on April 16 falling by 58.33% compared to the 5-day average. This decline in trading activity may reflect waning investor interest, contributing to the stock's current downward movement. <BR><BR>Overall, while Aakaar Medical Technologies Ltd has shown some positive trends in the short term, the combination of underperformance today, lower investor participation, and mixed moving averages has led to the current decline in its stock price.

Which are the latest news on Aakaar Medical?